[ad_1]
Atlantic Health System, in an effort to use artificial intelligence to both optimize and personalize medication management, announced Tuesday a commercial partnership with Israel-based FeelBetter, a leading provider of polypharmacy patient management technology.
Officials from both groups said the partnership will be activated with an initial focus on utilizing FeelBetter’s Pharmaco-Clinical Intelligence to flag patients who are at high risk of near-term hospitalization related to polypharmacy issues (simultaneous use of five or more medications), recommend changes to medication regimens and other needed clinical interventions and comprehensively monitor care journeys at the individual and population health levels.
FeelBetter’s platform will be rolled out in 2024 to support polypharmacy management for patients via Atlantic Health’s three accountable care organizations, which serve more than 100,000 Medicare beneficiaries and over 420,000 commercially attributed beneficiaries.
Dr. Thomas Kloos, president of Atlantic Accountable Care Organization, said the technology matches the mission of the organization.
“At Atlantic Health System, adopting new AI-based technologies with the potential to enhance health care is part of our unwavering commitment to providing high-quality, safe, affordable patient care,” he said.
“In partnering with FeelBetter, we’re taking another step forward in fulfilling our mission. Tackling the tremendous challenges associated with polypharmacy, where patients take multiple medications for multiple chronic diseases and conditions, is critical to improving health outcomes and quality of life, controlling costs and keeping our senior patients healthy in their homes across our communities for as long as possible.”
Dr. Jim Barr, vice president of clinical intelligence at Atlantic Health System, agreed.
“In addition to physicians, clinical pharmacists play an integral role in care teams, particularly when it comes to managing polypharmacy patients,” he said. “We’re looking forward to arming our team members with FeelBetter’s Pharmaco-Clinical Intelligence, a tool designed to automate manual processes and scale the personalized support physicians and clinical pharmacists provide to patients to ensure appropriate care and that medication regimens are safe and effective.”
A growing public health concern for senior patients, many of whom have multiple chronic conditions, the simultaneous use of multiple medications paves the way for poor health outcomes, increased use of health services and rising care costs. In the U.S. alone, every year, suboptimal medication management results in 275,000 deaths and more than $528 billion in avoidable costs.
FeelBetter co-founder and CEO Liat Primor said his group is eager to work with Atlantic Health.
“FeelBetter developed Pharmaco-Clinical Intelligence, a new category of technology that combines AI and novel pharmacology and clinical capabilities, to solve polypharmacy-related challenges and enable new levels of precision in disease management and prevention,” she said.
“We’re thrilled to be embarking on this journey with Atlantic Health and working together to deliver a more personalized, whole-patient approach to polypharmacy management — one that goes beyond a single illness, diagnosis or point in time, and comprehensively focuses on care journeys, both at the individual and population health levels.”
[ad_2]
Source_link
